Minaris Advanced Therapies
Shannon Hagan is an experienced professional in the field of microbiology and sterility assurance. Currently serving as a Sterility Assurance Technical Writer II at Minaris Advanced Therapies since May 2025, Shannon previously held the position of Microbiologist II at Penn Life Sciences from April 2021 to May 2025 and worked as a Microbiologist at EMSL Analytical, Inc. from August 2019 to April 2021. Shannon earned a Bachelor's degree in Biology from Holy Family University in 2019 and is currently pursuing a Master of Science degree at the University of Florida, which commenced in January 2025.
This person is not in any teams
This person is not in any offices
Minaris Advanced Therapies
1 followers
Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider focused exclusively on cell and gene therapies. Minaris Advanced Therapies is headquartered in Philadelphia, Pennsylvania, and has more than 730,000 square feet of infrastructure across the United States, Europe and Asia. We have manufactured and released over 7,500 GMP batches and our global network supports therapy developers through early-stage development, clinical trials and commercial manufacturing. By combining scientific expertise with best-in-class manufacturing and testing services, we help bring safe, effective therapies to patients faster and more efficiently. With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. Minaris Advanced Therapies is wholly owned by Altaris, LLC.